Case Report January 11, 2024

Seizures in a Young Woman Due to N-Methyl-D-Aspartate Receptor Antibody Encephalitis With Unremarkable Imaging Evaluations

; ; ; ; ; ; ;

Prim Care Companion CNS Disord 2024;26(1):23cr03510

  1. Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol. 2014;34(4):458–466. PubMed CrossRef
  2. Nougaret S, Cunha TM. From ovary to brain: Specific imaging features of ovarian teratomas associated with anti-N–methyl-d-aspartate receptor encephalitis. Diagn Interv Imaging. 2021;102(7–8):403–404. PubMed CrossRef
  3. Vargas RJ, Farid H, Goldenson RP, et al. Ovarian teratomas and anti–N-methyl-d-aspartate receptor encephalitis: why sonography first? J Ultrasound Med. 2016;35(4):852–854. PubMed CrossRef
  4. Steriade C, Britton J, Dale RC, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia. 2020;61(7):1341–1351. PubMed CrossRef
  5. Flannery P, Yang I, Keyvani M, et al. Acute psychosis due to anti- N–methyl-d-aspartate receptor receptor encephalitis following COVID-19 vaccination: a case report. Front Neurol. 2021;12:764197. PubMed CrossRef
  6. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. PubMed CrossRef
  7. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the Confusion Assessment Method: a new method for detection of delirium. Ann Intern Med. 1990;113(12):941–948. PubMed CrossRef
  8. Dai Y, Zhang J, Ren H, et al. Surgical outcomes in patients with anti–N-methyl-d-aspartate receptor encephalitis with ovarian teratoma. Am J Obstet Gynecol. 2019;221(5):485.e1–485.e10. PubMed CrossRef
  9. Cirkel C, Cirkel A, Royl G, et al. On the quest for hidden ovarian teratomas in therapy-refractory anti-NMDA receptor encephalitis: a case report. Neurol Res Pract. 2022;4(1):15. PubMed CrossRef
  10. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–165. PubMed CrossRef
  11. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2(5):200–215. PubMed CrossRef
  12. Maramattom BV, Jacob A. N–methyl-d-aspartate receptor encephalitis: a new addition to the spectrum of autoimmune encephalitis. Ann Indian Acad Neurol. 2011;14(3):153–157. PubMed CrossRef
  13. Cleverly K, Gambadauro P, Navaratnarajah R. Paraneoplastic anti- N–methyl-d-aspartate receptor encephalitis: have you checked the ovaries? Acta Obstet Gynecol Scand. 2014;93(7):712–715. PubMed CrossRef
  14. Bartolini L. Practice current: how do you treat anti-NMDA receptor encephalitis? Neurol Clin Pract. 2016;6(1):69–72. PubMed CrossRef